Live Cell Encapsulation Market Research Report Information by Manufacturing Technique (Simple Dripping, Electrostatic Dripping), Polymer Type (Alginate, HEMA-MMA, Chitosan, PAN-PVC), Application (Drug Delivery & Others), And by Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Live Cell Encapsulation Market, by Manufacturing Technique

6.1 Overview

6.2 Simple Dripping

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Electrostatic Dripping

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Coaxial Airflow

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5 Rotating Disk Atomization

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.6 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Live Cell Encapsulation Market, by Polymer Type

7.1 Overview

7.2 Alginate

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 HEMA-MMA

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 Chitosan

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5 Silica

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6 Cellulose Sulfate

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.7 PAN-PVC

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.8 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8. Global Live Cell Encapsulation Market, by Application

8.1 Overview

8.2 Drug Delivery

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Regenerative Medicine

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Cell Transplantation

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9. Global Live Cell Encapsulation Market, by Region

9.1 Overview

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Company Share Analysis

Chapter 11. Company Profiles

11.1 Balchem Corporation

11.1.1 Company Overview

11.1.2 Product Type Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Biotime, Inc.

11.2.1 Company Overview

11.2.2 Product Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Blacktrace Holdings Ltd.

11.3.1 Company Overview

11.3.2 Product Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Encapsys, LLC

11.4.1 Company Overview

11.4.2 Product Type Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 BÜCHI Labortechnik AG

11.5.1 Company Overview

11.5.2 Product Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Evonik Industries

11.6.1 Company Overview

11.6.2 Product Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Living Cell Technologies

11.7.1 Overview

11.7.2 Product Type Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Merck KGaA

11.8.1 Overview

11.8.2 Product Type Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Lycored

11.9.1 Overview

11.9.2 Product Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 MiKroCaps

11.10.1 Overview

11.10.2 Product Type Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Neurotech Holdings, LLC

11.11.1 Overview

11.11.2 Product Type Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Reed Pacific Pty Limited

11.12.1 Overview

11.12.2 Product Type Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Sernova Corporation

11.13.1 Overview

11.13.2 Product Type Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Sigilon Therapeutics, Inc.

11.14.1 Overview

11.14.2 Product Type Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Viacyte, Inc.

11.15.1 Overview

11.15.2 Product Type Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

11.16 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Live Cell Encapsulation Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Live Cell Encapsulation Market Synopsis, 2020–2027

Table 2 Global Live Cell Encapsulation Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Live Cell Encapsulation Market, by Manufacturing Technique, 2020–2027 (USD Million)

Table 4 Global Live Cell Encapsulation Market, by Polymer Type, 2020–2027 (USD Million)

Table 5 Global Live Cell Encapsulation Market, by Application, 2020–2027 (USD Million)

Table 6 Global Live Cell Encapsulation Market, by Region, 2020–2027 (USD Million)

Table 7 North America: Live Cell Encapsulation Market, by Manufacturing Technique, 2020–2027 (USD Million)

Table 8 North America: Live Cell Encapsulation Market, by Polymer Type, 2020–2027 (USD Million)

Table 9 North America: Live Cell Encapsulation Market, by Application, 2020–2027 (USD Million)

Table 10 US: Live Cell Encapsulation Market, by Manufacturing Technique, 2020–2027 (USD Million)

Table 11 US: Live Cell Encapsulation Market, by Polymer Type, 2020–2027 (USD Million)

Table 12 US: Live Cell Encapsulation Market, by Application, 2020–2027 (USD Million)

Table 13 Canada: Live Cell Encapsulation Market, by Manufacturing Technique, 2020–2027 (USD Million)

Table 14 Canada: Live Cell Encapsulation Market, by Polymer Type, 2020–2027 (USD Million)

Table 15 Canada: Live Cell Encapsulation Market, by Application, 2020–2027 (USD Million)

Table 16 South America: Live Cell Encapsulation Market, by Manufacturing Technique, 2020–2027 (USD Million)

Table 17 South America: Live Cell Encapsulation Market, by Polymer Type, 2020–2027 (USD Million)

Table 18 South America: Live Cell Encapsulation Market, by Application, 2020–2027 (USD Million)

Table 19 Europe: Live Cell Encapsulation Market, by Manufacturing Technique, 2020–2027 (USD Million)

Table 20 Europe: Live Cell Encapsulation Market, by Polymer Type, 2020–2027 (USD Million)

Table 21 Europe: Live Cell Encapsulation Market, by Application, 2020–2027 (USD Million)

Table 22 Western Europe: Live Cell Encapsulation Market, by Manufacturing Technique, 2020–2027 (USD Million)

Table 23 Western Europe: Live Cell Encapsulation Market, by Polymer Type, 2020–2027 (USD Million)

Table 24 Western Europe: Live Cell Encapsulation Market, by Application, 2020–2027 (USD Million)

Table 25 Eastern Europe: Live Cell Encapsulation Market, by Manufacturing Technique, 2020–2027 (USD Million)

Table 26 Eastern Europe: Live Cell Encapsulation Market, by Polymer Type, 2020–2027 (USD Million)

Table 27 Eastern Europe: Live Cell Encapsulation Market, by Application, 2020–2027 (USD Million)

Table 28 Asia-Pacific: Live Cell Encapsulation Market, by Manufacturing Technique, 2020–2027 (USD Million) Table 29 Asia-Pacific: Live Cell Encapsulation Market, by Polymer Type, 2020–2027 (USD Million)

Table 30 Asia-Pacific: Live Cell Encapsulation Market, by Application, 2020–2027 (USD Million)

Table 31 Middle East & Africa: Live Cell Encapsulation Market, by Manufacturing Technique, 2020–2027 (USD Million)

Table 32 Middle East & Africa: Live Cell Encapsulation Market, by Polymer Type, 2020–2027 (USD Million)

Table 33 Middle East & Africa: Live Cell Encapsulation Market, by Application, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Live Cell Encapsulation Market

Figure 3 Market Dynamics for Global Live Cell Encapsulation Market

Figure 4 Global Live Cell Encapsulation Market Share, by Manufacturing Technique, 2020

Figure 5 Global Live Cell Encapsulation Market Share, by Polymer Type, 2020

Figure 6 Global Live Cell Encapsulation Market Share, by Application, 2020

Figure 7 Global Live Cell Encapsulation Market Share, by Region, 2020

Figure 8 North America: Live Cell Encapsulation Market Share, by Country, 2020

Figure 9 Europe: Live Cell Encapsulation Market Share, by Country, 2020

Figure 10 Asia-Pacific: Live Cell Encapsulation Market Share, by Country, 2020

Figure 11 Middle East & Africa: Live Cell Encapsulation Market Share, by Country, 2020

Figure 12 Global Live Cell Encapsulation Market: Company Share Analysis, 2020 (%)

Figure 13 Balchem Corporation: Key Financials

Figure 14 Balchem Corporation: Segmental Revenue

Figure 15 Balchem Corporation: Geographical Revenue

Figure 16 Biotime, Inc.: Key Financials

Figure 17 Biotime, Inc.: Segmental Revenue

Figure 18 Biotime, Inc.: Geographical Revenue

Figure 19 Blacktrace Holdings Ltd.: Key Financials

Figure 20 Blacktrace Holdings Ltd.: Segmental Revenue

Figure 21 Blacktrace Holdings Ltd.: Geographical Revenue

Figure 22 BÜCHI Labortechnik AG: Key Financials

Figure 23 BÜCHI Labortechnik AG: Segmental Revenue

Figure 24 BÜCHI Labortechnik AG: Geographical Revenue

Figure 25 Encapsys, LLC: Key Financials

Figure 26 Encapsys, LLC: Segmental Revenue

Figure 27 Encapsys, LLC: Geographical Revenue

Figure 28 Evonik Industries: Key Financials

Figure 29 Evonik Industries: Segmental Revenue

Figure 30 Evonik Industries: Geographical Revenue

Figure 31 Living Cell Technologies: Key Financials

Figure 32 Living Cell Technologies: Segmental Revenue

Figure 33 Living Cell Technologies: Geographical Revenue

Figure 34 Lycored: Key Financials

Figure 35 Lycored: Segmental Revenue

Figure 36 Lycored: Geographical Revenue

Figure 37 Merck KGaA: Key Financials

Figure 38 Merck KGaA: Segmental Revenue

Figure 39 Merck KGaA: Geographical Revenue

Figure 40 MiKroCaps: Key Financials

Figure 41 MiKroCaps: Segmental Revenue

Figure 42 MiKroCaps: Geographical Revenue

Figure 43 Neurotech Holdings, LLC: Key Financials

Figure 44 Neurotech Holdings, LLC: Segmental Revenue

Figure 45 Neurotech Holdings, LLC: Geographical Revenue

Figure 46 Reed Pacific Pty Limited: Key Financials

Figure 47 Reed Pacific Pty Limited: Segmental Revenue

Figure 48 Reed Pacific Pty Limited: Geographical Revenue

Figure 49 Sernova Corporation: Key Financials

Figure 50 Sernova Corporation: Segmental Revenue

Figure 51 Sernova Corporation: Geographical Revenue

Figure 52 Sigilon Therapeutics, Inc.: Key Financials

Figure 53 Sigilon Therapeutics, Inc.: Segmental Revenue

Figure 54 Sigilon Therapeutics, Inc.: Geographical Revenue

Figure 55 Viacyte, Inc.: Key Financials

Figure 56 Viacyte, Inc.: Segmental Revenue

Figure 57 Viacyte, Inc.: Geographical Revenue